Olga Petryna, MD
Opted out of Medicare from October 2025 to October 2027. Internal Medicine, Rheumatology (MD) in New York, New York, licensed in NY and NJ, with an NPI issued in May 2009. Their prescriptions cost Medicare Part D more than their services did: $1,120,423 for 687 claims, against $37,371 paid for services in 2024. Janssen Biotech, Inc. was the largest of 8 companies reporting payments in 2025, $120,978 in all, mostly speaking and faculty fees.
Overview
| NPI | 1386878577 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | Yes |
| NPI issued | May 4, 2009 |
| Last updated in NPPES | Jul 11, 2022 |
| Certified by provider | Jul 11, 2022 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Rheumatology Primary | 207RR0500X | 261798 | NY |
| Internal Medicine, Rheumatology | 207RR0500X | 25MA09268800 | NJ |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Nov 10, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 11, 2026 | No match | — |
| New York OMIG · Nov 11, 2026 | No match | — |
| Ohio Medicaid · Nov 11, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 11, 2026 | No match | — |
| Washington HCA · Nov 11, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Not in the public enrollment file of Oct 1, 2026 |
|---|---|
| Opt-out | Opted out Oct 1, 2025 – Oct 1, 2027 |
| Can order and refer | Yes |
| Accepts assignment | Yes (participating) |
During an opt-out period the provider sees Medicare patients only under private contracts, and Medicare does not pay claims for their services.
Medicare services in 2024
| Medicare patients | 158 |
|---|---|
| Services billed | 903 across 19 procedure codes |
| Paid by Medicare | $37,371 |
Part D prescriptions in 2024
| Prescriptions (claims) | 687 · 1,144 30-day fills |
|---|---|
| Patients | 136 |
| Total drug cost | $1,120,423 |
| Generic share | 77% of claims |
Industry payments (Open Payments)
- 2025$120,978 · 90 payments from 8 companies
- 2024$67,303 · 61 payments from 10 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Janssen Biotech, Inc. | $76,490 | 49 |
| Astrazeneca Pharmaceuticals LP | $37,997 | 26 |
| Mallinckrodt Hospital Products Inc. | $5,712 | 4 |
| Genzyme Corporation | $283.54 | 3 |
| Amgen Inc. | $275.00 | 2 |
What the 2025 payments were for
- Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program$113,621 · 35 payments
- Travel and Lodging$4,296 · 22 payments
- Food and Beverage$2,962 · 32 payments
- Education$99.00 · 1 payment
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other rheumatologists in New York
- 1003891623
- 1013144120
- 1013970078
- 1033183181
- 1033187463
- 1043665490
- 1053652834
- 1063867422
- 1073925913
- 1083715833
- 1164884409
- 1174056550
All 218 rheumatologists in New York · All rheumatologists in New York